(Tyr0)-prepro-atrial natriuretic factor (104-123) (human)(CAS: 309245-24-7)

The (Tyr0)-prepro-atrial natriuretic factor (104-123) (human) (CAS: 309245-24-7) is subject to various regulatory guidelines including GHS for classification under hazardous substances, REACH regulations for registration, evaluation, and authorization of chemicals in the EU, and FDA/EPA requirements for safety and environmental protection in the United States. It is important to follow these guidelines for safe handling and disposal.

In synthesis, there are several alternatives to (Tyr0)-prepro-atrial natriuretic factor (104-123) (human) (CAS: 309245-24-7), such as analogs like (Tyr0)-prepro-atrial natriuretic factor (105-123) (human) and isomers. Common alternative reagents include different amino acid derivatives and synthetic techniques that can produce similar peptides with varying functional properties.

The market and research trend for (Tyr0)-prepro-atrial natriuretic factor (104-123) (human) (CAS: 309245-24-7) is focused on its potential in cardiovascular research and therapy due to its natriuretic and vasodilatory properties. There is an increasing interest in its use as a model compound for studying cardiovascular diseases and developing therapeutic applications. Price trends and industry demand are also influenced by advancements in biotechnology and pharmaceutical research.

Waste containing (Tyr0)-prepro-atrial natriuretic factor (104-123) (human) (CAS: 309245-24-7) should be carefully collected and stored in appropriate containers to prevent leakage or contamination. For disposal, it is recommended to follow local regulations and guidelines for hazardous waste. Professional waste disposal services are often the best option for safe incineration or other environmentally friendly methods to ensure compliance with safety and environmental protection standards.